The Association Between Depression, Lung Function, and Health-Related Quality of Life Among Adults With Cystic Fibrosis
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Background More than 40% of people born with cystic fibrosis (CF) now reach adulthood. Greater attention is being focused on improving their health-related quality of life (HRQoL). While markers of disease severity such as lung function are only modestly associated with HRQoL, in other chronic illnesses depression is an important correlate. The objective of this study was to evaluate the relationships among lung function (ie, FEV(1) percent predicted), depressive symptoms, and HRQoL among adults with CF.Methods Seventy-six adults with CF completed a mail-based survey. The Beck Depression Inventory and the Cystic Fibrosis Questionnaire were used to assess depressive symptoms and HRQoL, respectively. Values for FEV(1) percent predicted were abstracted from the medical record.Results Thirty percent of participants screened positive for depressive symptoms. Depressive symptoms and lung function were inversely correlated (rho = -0.25; p < .05). Correlations between depressive symptoms and HRQoL were maintained after stratifying by lung function. In the absence of depressive symptoms, those patients with good lung function (ie, FEV(1), > 70% predicted) reported better physical HRQoL than those with poor lung function. Participants with both depressive symptoms and poor lung function reported significantly worse HRQoL on all domains than participants without depressive symptoms regardless of lung function status.Conclusions Depressive symptoms are prevalent among adults with CF and are associated with poorer HRQoL even after controlling for lung function. These results suggest that screening for and treating depression is important and may potentially improve HRQoL among patients with CF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For adults with CF, rates of depression have ranged from 13% to 30%”
In the citing paper
“The prevalence of psychological distress is also high across a variety of chronic respiratory conditions, including cystic fibrosis (CF), non-CF bronchiectasis, and chronic obstructive pulmonary disease (COPD).Rates of depression and anxiety in these conditions have ranged from 20% to over 51% [7,8].”
From Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: Implementation of the Mental Health Guidelines (2020) · cites this paper as [7]
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., Belousova, E. G., Xuan, W., & Bye, P. T. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043900 · Cited by 862
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Mortality after hospitalization for COPD
Almagro, P., Calbo, E., Ochoa de Echaguïen, A., Barreiro, B., Quintana, S., Heredia, J. L., & Garau, J. (2002) · Chest · doi:10.1378/chest.121.5.1441 · Cited by 630
Even minimal symptoms of depression increase mortality risk after acute myocardial infarction
Bush, D. E., Ziegelstein, R. C., Tayback, M., Richter, D., Stevens, S., Zahalsky, H., & Fauerbach, J. A. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01675-7 · Cited by 620
Cited by
Ratjen, F., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 546
Quittner, A. L., Goldbeck, L., Abbott, J., Duff, A., Lambrecht, P., Solé, A., Tibosch, M. M., Bergsten Brucefors, A., Yüksel, H., Catastini, P., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205983 · Cited by 524
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., Marshall, B., Sabadosa, K. A., & Elborn, S. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207488 · Cited by 465
MacKenzie, T., Gifford, A. H., Sabadosa, K. A., Quinton, H. B., Knapp, E. A., Goss, C. H., & Marshall, B. C. (2014) · Annals of Internal Medicine · doi:10.7326/m13-0636 · Cited by 355
“Roughly 30% of older adults with CF have depression, which has negative consequences for health-related quality of life regardless of lung function (43).”
Pulmonary medication adherence and health-care use in cystic fibrosis
Quittner, A. L., Zhang, J., Marynchenko, M., Chopra, P. A., Signorovitch, J., Yushkina, Y., & Riekert, K. A. (2014) · Chest · doi:10.1378/chest.13-1926 · Cited by 250
Self-citationQuality of life in rare genetic conditions: A systematic review of the literature
Cohen, J. S., & Biesecker, B. B. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33380 · Cited by 197
“All six studies that measured psychological well-being found strong negative associations with QoL [Piccininni et al., 2004; Carel et al., 2005; Szyndler et al., 2005; Antonini et al., 2006; Riekert et al., 2007; Havermans et al., 2008].”
BackgroundSmith, B. A., Modi, A. C., Quittner, A. L., & Wood, B. L. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21238 · Cited by 185
“Furthermore depression was correlated with both lung function and health-related quality of life.(26) One primary aim of the current study was to extend this research on depressive symptoms to children and adolescents with CF, and assess its association with treatment adherence.”
BackgroundHabib, A.-R. R., Manji, J., Wilcox, P. G., Javer, A. R., Buxton, J. A., & Quon, B. S. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201408-393oc · Cited by 134
Quality of life in patients with Cystic Fibrosis: association with anxiety and depression
Havermans, T., Colpaert, K., & Dupont, L. J. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.05.010 · Cited by 124
“[4] found depressive symptoms to be prevalent among adults with CF and associated with poorer HRQoL even after controlling for lung function.”
BackgroundResultDepression is a common and chronic comorbidity in patients with interstitial lung disease
RYERSON, C. J., AREAN, P. A., BERKELEY, J., CARRIERI‐KOHLMAN, V. L., PANTILAT, S. Z., LANDEFELD, C. S., & COLLARD, H. R. (2012) · Respirology · doi:10.1111/j.1440-1843.2011.02122.x · Cited by 122
Prevalence and impact of depression in cystic fibrosis
Quittner, A. L., Barker, D. H., Snell, C., Grimley, M. E., Marciel, K., & Cruz, I. (2008) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283121cf1 · Cited by 110
Depression, illness severity, and healthcare utilization in cystic fibrosis
Snell, C., Fernandes, S., Bujoreanu, I. S., & Garcia, G. (2014) · Pediatric Pulmonology · doi:10.1002/ppul.22990 · Cited by 108
“This is in line with the adult population with CF, where the presence of depression negatively affects lung respiratory function, quality of life, and therapeutic regimen adherence and in turn leads to increased need for inpatient and outpatient medical care.(10)”
ResultDepression and anxiety symptoms in bronchiectasis: associations with health-related quality of life
Olveira, C., Olveira, G., Gaspar, I., Dorado, A., Cruz, I., Soriguer, F., Quittner, A. L., & Espíldora, F. (2012) · Quality of Life Research · doi:10.1007/s11136-012-0188-5 · Cited by 111
“symptoms in patients with bronchiectasis, a higher prevalence of these symptoms has been reported, with greater functional impairment documented in those with versus those without a psychiatric disorder [4, 12, 18].”
BackgroundResultInfluentialThe psychological burden of cystic fibrosis
Quittner, A. L., Saez-Flores, E., & Barton, J. D. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000244 · Cited by 102
Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis
Yohannes, A. M., Willgoss, T. G., Fatoye, F. A., Dip, M. D., & Webb, K. (2012) · Respiratory Care · doi:10.4187/respcare.01328 · Cited by 96
Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis
Goldbeck, L., Besier, T., Hinz, A., Singer, S., & Quittner, A. L. (2010) · Chest · doi:10.1378/chest.09-2940 · Cited by 89
Anxiety and Depression in Cystic Fibrosis
Cruz, I., Marciel, K., Quittner, A., & Schechter, M. (2009) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0029-1238915 · Cited by 83
“After controlling for lung function, adults with CF who reported anxious symptoms also had lower HRQOL scores on the Cystic Fibrosis Questionnaire-Revised (CFQ-R), a diseasespecific measure, on the following scales: vitality, emo- tional and social functioning, treatment burden, health perceptions, and respiratory sym…”
ResultInfluentialPulmonary Rehabilitation for Respiratory Disorders Other than Chronic Obstructive Pulmonary Disease
Rochester, C. L., Fairburn, C. L., & Crouch, R. H. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.02.016 · Cited by 97
Talwalkar, J. S., Koff, J. L., Lee, H. B., Britto, C. J., Mulenos, A. M., & Georgiopoulos, A. M. (2017) · Psychosomatics · doi:10.1016/j.psym.2017.04.001 · Cited by 85
Knudsen, K. B., Pressler, T., Mortensen, L. H., Jarden, M., Skov, M., Quittner, A. L., Katzenstein, T. L., & Boisen, K. A. (2016) · SpringerPlus · doi:10.1186/s40064-016-2862-5 · Cited by 91
“(Havermans et al. 2008; Riekert et al. 2007; Yohannes et al. 2012).”
BackgroundMedication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis.
Hilliard, M. E., Eakin, M. N., Borrelli, B., Green, A., & Riekert, K. A. (2015) · Health Psychology · doi:10.1037/hea0000136 · Cited by 77
“Moderate elevations in depression symptoms (including nearly one quarter with clinically significant symptom levels) were likewise consistent with previously published rates (Goldbeck et al., 2010; Latchford & Duff, 2013; Riekert et al., 2007).”
Self-citationDecreased survival in cystic fibrosis patients with a positive screen for depression
Schechter, M. S., Ostrenga, J. S., Fink, A. K., Barker, D. H., Sawicki, G. S., & Quittner, A. L. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.07.020 · Cited by 71
Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
Parkins, M. D., Parkins, V. M., Rendall, J. C., & Elborn, J. S. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810386051 · Cited by 70
“increased in CF adults relative to the general population at approximately 30% [Riekert et al. 2007; Pearson et al. 1991].”
BackgroundAdherence and psychopathology in children and adolescents with cystic fibrosis
White, T. J. H., Miller, J. N., Smith, G. L., & McMahon, W. M. (2008) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-008-0709-5 · Cited by 82
“Higher rates of maternal emotional distress [5, 11, 55] and depression [45] are commonly reported.”
BackgroundAnxiety and depression in adolescents with CF and their caregivers
Besier, T., & Goldbeck, L. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.06.012 · Cited by 87
“This is crucial, keeping inmind negative effects on quality of life and mental health outcomes [13,23,37]as well as subsequent problems of untreated psychological symptoms (cf.”
BackgroundHospital Readmission of Adolescents and Young Adults With Complex Chronic Disease
Dunbar, P. J., Hall, M., Gay, J. C., Hoover, C. G., Markham, J. L., Bettenhausen, J. L., Perrin, J. M., Kuhlthau, K. A., Crossman, M. K., Garrity, B. M., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7613 · Cited by 68
Screening for cystic fibrosis-related diabetes: a systematic review.
Waugh, N., Royle, P., Craigie, I., Ho, V, Pandit, L., Ewings, P., Adler, A., Helms, P., & Sheldon, C. (2012) · Health Technology Assessment · doi:10.3310/hta16240 · Cited by 63
Nongenetic influences on cystic fibrosis outcomes
Schechter, M. S. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834ba899 · Cited by 67
Health related quality of life in cystic fibrosis: To work or not to work?
Havermans, T., Colpaert, K., Vanharen, L., & Dupont, L. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.03.002 · Cited by 63
“Several researchers have measured HRQoL in patients with CF in relation to psychosocial, demographic and/or clinical factors [2–6] and CF-specific measures of HRQoL in different languages have been developed [7–9].”
BackgroundResultCronly, J., Duff, A. J. A., Riekert, K. A., Fitzgerald, T., Perry, I. J., Lehane, E. A., Horgan, A. M., Howe, B., Chróinín, M. N., & Savage, E. (2018) · Respiratory Care · doi:10.4187/respcare.06356 · Cited by 66
Self-citationAcceptance and well-being in adolescents and young adults with cystic fibrosis: A prospective study
Casier, A., Goubert, L., Theunis, M., Huse, D., De Baets, F., Matthys, D., & Crombez, G. (2011) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsq111 · Cited by 60
Quittner, A. L., Abbott, J., Hussain, S. B., Ong, T., Uluer, A., Hempstead, S. E., Lomas, P., & Smith, B. A. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24949 · Cited by 62
Abbott, J., Elborn, J. S., Georgiopoulos, A. M., Goldbeck, L., Marshall, B. C., Sabadosa, K. A., Smith, B. A., & Quittner, A. L. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.12.015 · Cited by 63
“pulmonary function, self-management and health-related quality of life [5-8], in addition to increased hospitalizations and health care costs [9].”
BackgroundQuon, B. S., Bentham, W. D., Unutzer, J., Chan, Y.-F., Goss, C. H., & Aitken, M. L. (2015) · Psychosomatics · doi:10.1016/j.psym.2014.05.017 · Cited by 53
Piehler, L., Thalemann, R., Lehmann, C., Thee, S. A., Roehmel, J. F., Syunyaeva, Z., Stahl, M., Mall, M. A., & Graeber, S. Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1179208 · Cited by 59
“Symptoms of depression and anxiety are associated with reduced quality of life and adherence to airway clearance treatment (Riekert et al., 2007; Smith et al., 2010; Yohannes et al., 2012), as well as disease progression including decline in lung function, an increased rate of pulmonary exacerbations and increased mor…”
BackgroundCystic Fibrosis: What to Expect now in the Early Adult Years
Quon, B. S., & Aitken, M. L. (2012) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2012.03.005 · Cited by 61
Duff, A. J. A., Abbott, J., Cowperthwaite, C., Sumner, C., Hurley, M. A., & Quittner, A. L. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.02.010 · Cited by 62
“The combination of depression and poor lung-function had a greater adverse effect on QoL than poor lung-function alone [10].”
BackgroundLord, L., McKernon, D., Grzeskowiak, L. E., Kirsa, S. W., & Ilomäki, J. (2022) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-022-02307-w · Cited by 56
Bouka, A., Tiede, H., Liebich, L., Dumitrascu, R., Hecker, C., Reichenberger, F., Mayer, K., Seeger, W., & Schulz, R. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.06.010 · Cited by 53
Fidika, A., Herle, M., & Goldbeck, L. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-205 · Cited by 46
“Likewise in patients with CF symptoms of depression are inversely associated with lung function [12,22].”
BackgroundInfluentialSuicide attempts in adolescents with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor therapy
Arslan, M., Chalmers, S. J., Rentfrow, K., Olson, J. M., Dean, V., Wylam, M. E., & Demirel, N. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.01.015 · Cited by 46
Modi, A. C., Driscoll, K. A., Montag‐Leifling, K., & Acton, J. D. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21334 · Cited by 57
“Regardless of the temporal relations between depression and anxiety and consistent with prior research,16–19 a significant association was found between symptoms of depression and anxiety in adolescents and young adults with CF. Data from the extant literature suggest that depressive symptoms increase as patients with…”
BackgroundMethodResultInfluentialChest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease?
Loeve, M., Krestin, G. P., Rosenfeld, M., de Bruijne, M., Stick, S. M., & Tiddens, H. A. W. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00051512 · Cited by 51
Wood, J., Jenkins, S., Putrino, D., Mulrennan, S., Morey, S., Cecins, N., Bear, N., & Hill, K. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.09.002 · Cited by 42
Management Issues for Adolescents with Cystic Fibrosis
Withers, A. (2012) · Pulmonary Medicine · doi:10.1155/2012/134132 · Cited by 54
“Many studies highlight the fact that not only is depression common in adolescents with CF but has significant negative effects on quality of life, adherence to treatment, and family functioning (which is vital to effective care for an adolescent with CF) [21, 27, 33, 36, 37].”
BackgroundPsychiatric aspects of chronic lung disease
Jain, A., & Lolak, S. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0034-9 · Cited by 42
“In addition, participants with depressive symptoms and poor lung function reported signifi cantly worse health-related quality of life on all domains than participants with poor lung function alone, suggesting a synergistic effect between depressive symptoms and lung function [ 52 ].”
BackgroundLongitudinal association between lung function and health-related quality of life in cystic fibrosis
Abbott, J., Hurley, M. A., Morton, A. M., & Conway, S. P. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202552 · Cited by 47
“Conversely, depressive symptoms were associated with a poorer HRQoL across all CFQ domains.(32) Screening for and treating depression may improve HRQoL, and further robust studies using multivariate modelling are required to assess the impact of mood on HRQoL and clinical status.”
BackgroundMental Health screening in cystic fibrosis centres across Europe
Abbott, J., Havermans, T., Jarvholm, S., Landau, E., Prins, Y., Smrekar, U., Staab, D., Verity, L., & Verkleij, M. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.09.003 · Cited by 40
Development and evaluation of a palliative care curriculum for cystic fibrosis healthcare providers
Linnemann, R. W., O’Malley, P. J., Friedman, D., Georgiopoulos, A. M., Buxton, D., Altstein, L. L., Sicilian, L., Lapey, A., Sawicki, G. S., & Moskowitz, S. M. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.03.005 · Cited by 43
“This burden of symptoms and treatments often has a significant detrimental effect on quality of life and adherence [6–11].”
BackgroundSmith, B. A., Georgiopoulos, A. M., Mueller, A., Abbott, J., Lomas, P., Aliaj, E., & Quittner, A. L. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.08.027 · Cited by 46
Maintaining mental health and function for the long run in cystic fibrosis
Smith, B. A., Georgiopoulos, A. M., & Quittner, A. L. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23522 · Cited by 39
Graziano, S., Spanò, B., Majo, F., Righelli, D., Vincenzina, L., Quittner, A., & Tabarini, P. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106147 · Cited by 40
Palliative and end-of-life care in cystic fibrosis: what we know and what we need to know
Robinson, W. M. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283304c29 · Cited by 38
Hosseini, S. H., Ghaemian, A., Mehdizadeh, E., & Ashraf, H. (2014) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2014.940049 · Cited by 42
“…does not necessarily lead to poorer QoL, which resonates with the previous fi nding that QoL is more consistently predicted by depression than by anxiety (Mayou et al. 2000; Lane et al. 2001; Dickens et al. 2006; Riekert et al. 2007; Frasure-Smith 2008; Svirtlih et al. 2008; Hanssen et al. 2009).”
BackgroundHealth-related quality of life in children with cystic fibrosis: validation of the German CFQ-R
Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-97 · Cited by 37
Catastini, P., Di Marco, S., Furriolo, M., Genovese, C., Grande, A., Iacinti, E., Iusco, D. R., Nobili, R. M. V., Pescini, R., Ragni, R., et al. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23566 · Cited by 36
Cronly, J., Duff, A. J. A., Riekert, K. A., Perry, I. J., Fitzgerald, T., Horgan, A. M., Lehane, E. A., Howe, B., Chróinín, M. N., & Savage, E. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019305 · Cited by 38
Self-citationOlveira, C., Solé, A., Girón, R. M., Quintana‐Gallego, E., Mondejar, P., Baranda, F., Alvarez, A., Prados, C., Rodríguez-González, J., Labarga, I. H., et al. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.02.002 · Cited by 35
“In patients with CF, these symptoms have been associated with worse adherence [12–19], worse pulmonary function [9,11,14,20,21], increased hospitalizations and health care costs [16,17,19], which implies that systematic screening should”
InfluentialOlveira, C., Olveira, G., Espíldora, F., Girón, R. M., Vendrell, M., Dorado, A., & Martínez‐García, M. Á. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.01.010 · Cited by 44
“These results are consistent with prior studies in which higher rates of depression and anxiety have been reported by patients with chronic illnesses [10,12,56], including patients with a variety of respiratory diseases [11,16,57–61] and bronchiectasis [4,9,15].”
BackgroundResultInfluentialBlackwell, L. S., & Quittner, A. L. (2014) · Pediatric Pulmonology · doi:10.1002/ppul.23091 · Cited by 36
Overcoming psychosocial challenges in cystic fibrosis: Promoting resilience
Muther, E., Polineni, D., & Sawicki, G. S. (2018) · Pediatric Pulmonology · doi:10.1002/ppul.24127 · Cited by 42
Bodnár, R., Kádár, L., Holics, K., Újhelyi, R., Kovács, L., Bolbas, K., Szekely, G., Gyurkovits, K., Sólyom, E., & Mészáros, Á. (2014) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-40-50 · Cited by 39
“Other investigators similarly described a negative weak, correlation between FEV1 and the Digestive symptoms domain of CFQ-R [24,28].”
ResultCystic Fibrosis Transitions of Care
Okumura, M. J., & Kleinhenz, M. E. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.11.007 · Cited by 36
“Toguideclinical practice, research, and policy, we then discuss the role of quality improvement initiatives as ameans to improve transition of care for patients with CF.”
BackgroundInfluentialHealth-related quality of life measurement in cystic fibrosis: advances and limitations
Abbott, J. (2009) · Chronic Respiratory Disease · doi:10.1177/1479972308098159 · Cited by 41
Friedman, D., Linnemann, R. W., Altstein, L. L., Islam, S., Bach, K., Lamb, C., Volpe, J., Doolittle, C., John, A. S., O’Malley, P. J., et al. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.02.011 · Cited by 33
Growing up with cystic fibrosis: achievement, life satisfaction, and mental health
Besier, T., & Goldbeck, L. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0096-0 · Cited by 36
Bahalı, K., Gedik, A. H., Bilgiç, A., Çakır, E., Kahraman, F. U., Osmanoğlu, N. K., Uzuner, S., & Kılıçoğlu, A. G. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.05.019 · Cited by 32
“Adult studies have generally reported that levels of psychological symptoms are higher among patients with bronchiectasis, and these symptoms worsen quality of life (QOL) in adult patients [7–9].”
BackgroundBody satisfaction, nutritional adherence, and quality of life in youth with cystic fibrosis
Simon, S. L., Duncan, C. L., Horky, S. C., Nick, T. G., Castro, M. S. M., & Riekert, K. A. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21477 · Cited by 39
Self-citationGuta, M. T., Tekalign, T., Awoke, N., Fite, R. O., Dendir, G., & Lenjebo, T. L. (2021) · International Journal of Chronic Diseases · doi:10.1155/2021/6708865 · Cited by 44
“Chronically ill patients experience emotional difficulties that can sometimes even manifest themselves in anxiety and depression [14].”
BackgroundForte, G. C., Barni, G. C., Perin, C., Casarotto, F. C., Fagondes, S. C., & Dalcin, P. D. T. R. (2015) · Respiratory Care · doi:10.4187/respcare.03665 · Cited by 28
Life satisfaction of adolescents and adults with cystic fibrosis: Impact of partnership and gender
Besier, T., Schmitz, T. G., & Goldbeck, L. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.10.001 · Cited by 27
“It is known that objective health parameters are only moderately associated with QoL [10,11],”
BackgroundPromoting emotional wellness in children with CF, part II: Mental health assessment and intervention
Georgiopoulos, A. M., Christon, L., Filigno, S. S., Mueller, A., Prieur, M. G., Boat, T. F., & Smith, B. A. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.24977 · Cited by 33
When Women with Cystic Fibrosis Become Mothers: Psychosocial Impact and Adjustments
Cammidge, S., Duff, A. J. A., Latchford, G. J., & Etherington, C. (2016) · Pulmonary Medicine · doi:10.1155/2016/9458980 · Cited by 32
Toprak, D., Nay, L., McNamara, S., Rosenberg, A. R., Rosenfeld, M., & Yi‐Frazier, J. P. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24574 · Cited by 28
Saez-Flores, E., Tonarely, N. A., Barker, D. H., & Quittner, A. L. (2018) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsx155 · Cited by 25
“Depressive symptoms have also been associated with more hospitalizations (Snell, Fernandes, Bujoreanu, & Garcia, 2014), worse pulmonary function (Riekert et al., 2007), and poorer rates of adherence (Smith et al.”
BackgroundPsychological distress in adults with and without cystic fibrosis during the COVID-19 lockdown
Ciprandi, R., Bonati, M. R., Campi, R., Pescini, R., & Castellani, C. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.12.016 · Cited by 28
Georgiopoulos, A. M., & Hua, L. L. (2011) · Psychosomatics · doi:10.1016/j.psym.2010.12.016 · Cited by 29
Clinical communication preferences in cystic fibrosis and strategies to optimize care
Cooley, L., Hudson, J. N., Potter, E., Raymond, K. F., George, C., & Georgiopoulos, A. M. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24655 · Cited by 25
Pham, H., Vandeleur, M., Mainzer, R., & Ranganathan, S. (2024) · Pediatric Pulmonology · doi:10.1002/ppul.27100 · Cited by 26
Vitamin D and Depressive Symptoms in Children with Cystic Fibrosis
Smith, B. A., Cogswell, A., & García, G. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.01.012 · Cited by 26
Ashish, A., Shaw, M., McShane, J., Ledson, M. J., & Walshaw, M. J. (2012) · JRSM Short Reports · doi:10.1258/shorts.2011.011119 · Cited by 24
Coping styles in adults with cystic fibrosis: implications for emotional and social quality of life
Hugh, R. M., McFeeters, D., Boyda, D., & O’Neill, S. M. (2015) · Psychology Health & Medicine · doi:10.1080/13548506.2015.1020317 · Cited by 30
The Evidence Regarding Exercise Training in the Management of Cystic Fibrosis: A Systematic Review
Shoemaker, M. J., Hurt, H., & Arndt, L. (2008) · Cardiopulmonary Physical Therapy Journal · doi:10.1097/01823246-200819030-00002 · Cited by 34
Psychiatric morbidity and quality of life in children and adolescents with cystic fibrosis
Şenses-Dinç, G., Özçelik, U., Esen, H. T. Ç., Doğru, D., cop, E., Yalçın, E., Kültür, S. E. Ç., Pekcan, S., Kiper, N., & Ünal, F. (2018) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2018.01.005 · Cited by 23
“Hospitalization duration (days)* 22 (3-300) 20 (1-180) Z=-1.”
Verkleij, M., Appelman, I., Altenburg, J., Twisk, J. W. R., Quittner, A. L., & Haarman, E. G. (2021) · ERJ Open Research · doi:10.1183/23120541.00274-2021 · Cited by 23
Kauser, S., Keyte, R., Regan, A., Nash, E. F., Fitch, G., Mantzios, M., & Egan, H. H. (2021) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-021-09831-y · Cited by 32
“Our findings on the relationships between quality of life and mental health align with previous findings in this population (Cronly et al., 2019a; Havermans et al., 2008; Platten et al., 2013; Riekert et al., 2007; Yohannes et al., 2012).”
BackgroundResultPsychological burden associated with worse clinical outcomes in sarcoidosis
Sharp, M., Brown, T., Chen, E., Rand, C. S., Möller, D. R., & Eakin, M. N. (2019) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2019-000467 · Cited by 22
Self-citationMental health and sense of coherence among Swedish adults with cystic fibrosis
Brucefors, A. B., Hjelte, L., & Hochwälder, J. (2010) · Scandinavian Journal of Caring Sciences · doi:10.1111/j.1471-6712.2010.00840.x · Cited by 22
Racial inequities and rare CFTR variants: Impact on cystic fibrosis diagnosis and treatment
Wu, M., Davis, J. D., Zhao, C., Daley, T. C., & Oliver, K. E. (2024) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2024.100344 · Cited by 25
Re-imagining cystic fibrosis care: next generation thinking
Rang, C., Keating, D., Wilson, J. W., & Kotsimbos, T. C. (2020) · European Respiratory Journal · doi:10.1183/13993003.02443-2019 · Cited by 19
Regional brain tissue changes in patients with cystic fibrosis
Roy, B., Woo, M. S., Vacas, S., Eshaghian, P. H., Rao, A. P., & Kumar, R. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03092-x · Cited by 23
Duff, A. J. A. (2015) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2015.07.006 · Cited by 17
“TIDES data unequivocally establishes which patients with CF are ‘at risk’ of developing depression [14,15] and when taken together with the links to poorer health outcomes [7–13], why should depression and anxiety not be placed under regular”
Chest CT abnormalities and quality of life: relationship in adult cystic fibrosis
Kilcoyne, A., Lavelle, L. P., McCarthy, C. J., McEvoy, S. H., Fleming, H., Gallagher, A., Loeve, M., Tiddens, H. A. W. M., McKone, E. F., Gallagher, C. C., et al. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.08 · Cited by 19
“It is also known that lung disease effects the prevalence and severity of depression in CF (35), which in turn affects aspects such as social and role functioning.”
BackgroundFriedman, D., Linnemann, R. W., Altstein, L. L., Georgiopoulos, A. M., Islam, S., Bach, K., John, A. S., Fracchia, M. S., Neuringer, I. P., Lapey, A., et al. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24311 · Cited by 20
Liu, F. F., Lew, A., Andes, E., McNamara, S., Cassidy, J., Whitmore, S., Plunkett, R., & Ong, T. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24951 · Cited by 18
Backström-Eriksson, L., Sorjonen, K., Brucefors, A. B., Hjelte, L., & Melin, B. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0117-9 · Cited by 20
“Furthermore, a small single-centre study [16] conducted in the US reported a depression prevalence of 30 %.”
BackgroundBreathlessness catastrophizing relates to poorer quality of life in adults with cystic fibrosis
Maras, D., Balfour, L., Tasca, G. A., Gaudet, E., Aaron, S. D., Cameron, D. W., & Pakhale, S. S. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.08.008 · Cited by 17
Executive functioning in pediatric cystic fibrosis: A preliminary study and conceptual model
Borschuk, A. P., Molitor, S. J., Everhart, R. S., Siracusa, C. M., & Filigno, S. S. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24648 · Cited by 17
Inpatient healthcare trends among adult cystic fibrosis patients in the U.S.
Kopp, B. T., Wang, W., Chisolm, D. J., Kelleher, K. J., & McCoy, K. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21535 · Cited by 16
Sherman, A. C., Simonton-Atchley, S., O’Brien, C. E., Campbell, D., Reddy, R. M., Guinee, B., Wagner, L. D., & Anderson, P. J. (2021) · Journal of Religion and Health · doi:10.1007/s10943-021-01185-x · Cited by 15
Metadata
- Authors
- Riekert, K. A., Bartlett, S. J., Boyle, M. P., Krishnan, J. A., & Rand, C. S.
- Affiliations
- Johns Hopkins University (US)
- University of Chicago (US)
- Corresponding author
- Riekert, Kristin A.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 132
- Issue
- 1
- Pages
- 231-237
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2155123865
- Cited by
- 197
- References
- 48
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 9 · 2023: 6 · 2022: 13 · 2021: 16 · 2020: 15 · 2019: 7 · 2018: 9 · 2017: 7 · 2016: 15 · 2015: 17 · 2014: 20 · 2013: 6 · 2012: 11
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32dk061135-01)
- National Heart, Lung, and Blood Institute (HL 63333)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 61135)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- cystic fibrosis, depression, depressive symptoms, lung function, health-related quality of life, FEV1 percent predicted, adults with cystic fibrosis, depression screening, chronic disease
- MeSH terms
- Adult, Aged, Cross-Sectional Studies, Cystic Fibrosis, Depression, Female, Forced Expiratory Volume, Health Surveys, Humans, Lung, Male, Middle Aged, Quality of Life, Severity of Illness Index, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.